-
ProductsOur company can produce anti-tumor, anti-fungal, antibiotics, nutrition, anesthesia, cardiovascular and cerebrovascular products such as 6 categories of series of products, the company's existing domestic products 73 product specifications and foreign products 22 product specifications.
-
NewsFrom 2019 to now, the company has attracted 38 kinds of generic drugs developed by 12 scientific research institutes such as Beijing Tongrentang Pharmaceutical Technology Development Co., Ltd. and Shanghai Rongdi Biotechnology Co., Ltd. to land in our company. After all of them are put into production, the annual output value can be increased by 1 billion and the profit can be about 0.2 billion.
The national exclusive product-non-PVC soft bag cimetidine sodium chloride injection was officially approved.
Date:
2017-01-01
2017-01-01 National Exclusive Product-Non-PVC Soft Bag Cimetidine Sodium Chloride Injection is the first-line drug for clinical treatment of digestive tract diseases. The company raised the research and development standard and carried out it according to the British Pharmacopoeia. There are many experimental items and high standard requirements. However, we overcame many difficulties and declared on schedule. On December 26, 2016, the State Food and Drug Administration officially approved our company to obtain production approval. This product is a national medical insurance category A variety, the advent of this product, will become my company's profit growth point.
2017-01-01
The national exclusive product-non-PVC soft bag cimetidine sodium chloride injection is the clinical treatment of digestive tract diseases of the first-line drug, the company to improve the research and development standards, in accordance with the British Pharmacopoeia, the experimental project is numerous, standard.The requirements are high, but we have overcome many difficulties to declare on schedule. On December 26, 2016, the State Food and Drug Administration officially approved our company to obtain production approval.
This product is a national medical insurance category A variety, the advent of this product, will become my company's profit growth point.
Key words:
Biopharmaceuticals
2023-07-02
Self-monitoring programme in 2023
2023-06-26
Fuze the world, a promise will be made!
Norcheng Pharmaceuticals
Copyright©2023 Shanxi Nuocheng Pharmaceutical Co., Ltd.